Home/Pipeline/KOP-002

KOP-002

Solid Tumors (Melanoma)

PreclinicalActive

Key Facts

Indication
Solid Tumors (Melanoma)
Phase
Preclinical
Status
Active
Company

About Kopra Bio

Kopra Bio engineers tumor cells to become in‑situ factories of immunotherapy, delivering localized, self‑amplifying cancer treatment.

View full company profile

Therapeutic Areas